Decreased Rates of Radiation-induced Trismus and Lowered Mastication Structure Doses in Patients Treated for Head and Neck Cancer During the Last Two Decades

被引:1
|
作者
Pettersson, N. [1 ,2 ]
Andersson, E. [3 ]
Pauli, N. [3 ,4 ]
Tuomi, L. [4 ,5 ]
Finizia, C. [3 ,4 ]
Olsson, C. E. [6 ]
机构
[1] Univ Gothenburg, Inst Clin Sci, Sahlgrenska Acad, Med Radiat Sci, Gothenburg, Sweden
[2] Sahlgrens Univ Hosp, Dept Med Phys & Biomed Engn, Western Sweden Healthcare Reg, Gothenburg, Sweden
[3] Univ Gothenburg, Inst Clin Sci, Sahlgrenska Acad, Dept Otorhinolaryngol Head & Neck Surg, Gothenburg, Sweden
[4] Sahlgrens Univ Hosp, Reg Vastra Gotaland, Dept Otorhinolaryngol Head & Neck Surg, Gothenburg, Sweden
[5] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Speech & Language Pathol Unit, Gothenburg, Sweden
[6] Reg Canc Ctr West, Reg Vastra Gotaland, Gothenburg, Sweden
关键词
3DCRT; Head-and-neck cancer; Radiation-induced trismus; Radiotherapy; Radiation therapy; VMAT; RADIOTHERAPY; THERAPY;
D O I
10.1016/j.clon.2024.07.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: To investigate how absorbed doses to mastication structures in modern radiotherapy (RT) technique for head and neck cancer (HNC) compared with earlier RT techniques and with published trismus tolerance doses. To compare the incidence of radiation-induced trismus by earlier and newer RT techniques. Materials and methods: This study investigated two HNC patient cohorts treated with RT in 2007-2012 (three-dimensional conformal radiotherapy [3DCRT] and/or intensity-modulated radiotherapy [IMRT]; n =121 [Cohort 1]) and 2017-2020 (volumetric-modulated arc therapy [VMAT]; n =124 [Cohort 2]). All patients underwent RT without mastication structure-sparing intent, had normal mouth-opening ability before RT, and were prospectively assessed. Trismus was defined as the maximal interincisal opening <= 35 mm at any follow-up (3-, 6-, and 12-months post-RT). The temporomandibular joints (TMJs), masseter, and medial/lateral pterygoid muscles were delineated on the planning CT:s. Mean doses were compared between cohorts, and evaluated with respect to published trismus tolerance doses. P values <= 0.05 indicated statistical significance. Results: Within 12 months post RT, 74/121 (61%) of patients in Cohort 1 had experienced trismus compared to 11/124 (9%) in Cohort 2. Averaged mean doses (+/- S.D.) for the masseter muscles were 35.2 +/- 8.3 Gy in Cohort 1 and 20.2 +/- 8.7 Gy in Cohort 2 (P <0.001). Corresponding numbers were 19.1 +/- 16.2 and 4.3 +/- 4.3 Gy for the TMJs, 53.7 +/- 10.1 and 40.2 +/- 16.8 Gy for the medial pterygoid muscles, and 29.2 +/- 18.7 and 9.2 +/- 8.4 Gy for the lateral pterygoid muscles (all P <0.001). Masseter muscle doses were below tolerance doses in 23% of patients in Cohort 1 compared with 90% in Cohort 2. The corresponding numbers were 52% and 96% for the TMJs, 8% and 36% for the medial pterygoid muscles and 72% and 100% for the lateral pterygoid muscles. Conclusion: Mastication structure mean doses by more recent RT techniques were generally below proposed tolerance doses, with dose reductions of 10-20 Gy compared with earlier techniques. Modern RT without mastication-structure-sparing intent resulted in below 10% of HNC patients experiencing trismus compared with 60% treated with earlier techniques. (c) 2024 The Authors. Published by Elsevier Ltd on behalf of The Royal College of Radiologists. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:e388 / e397
页数:10
相关论文
共 50 条
  • [1] Radiation-Induced trismus in head and neck cancer patients
    Kent, M. Louise
    Brennan, Michael T.
    Noll, Jenene L.
    Fox, Philip C.
    Burri, Stuart H.
    Hunter, Jane C.
    Lockhart, Peter B.
    SUPPORTIVE CARE IN CANCER, 2008, 16 (03) : 305 - 309
  • [2] Radiation-Induced trismus in head and neck cancer patients
    M. Louise Kent
    Michael T. Brennan
    Jenene L. Noll
    Philip C. Fox
    Stuart H. Burri
    Jane C. Hunter
    Peter B. Lockhart
    Supportive Care in Cancer, 2008, 16 : 305 - 309
  • [3] Risk structures for radiation-induced trismus in head and neck cancer
    Pauli, Nina
    Finizia, Caterina
    Olsson, Caroline E.
    Pettersson, Niclas
    Johansson, Mia
    Haugen, Hedda
    Wilderng, Ulrica
    Steineck, Gunnar
    ACTA ONCOLOGICA, 2016, 55 (06) : 788 - 792
  • [4] Temporomandibular disorder as risk factor for radiation-induced trismus in patients with head and neck cancer
    Pauli, Nina
    Mohlin, Bodil Fagerberg
    Mejersjo, Christina
    Finizia, Caterina
    CLINICAL AND EXPERIMENTAL DENTAL RESEARCH, 2022, 8 (01): : 123 - 129
  • [5] Dose-volume analysis of radiation-induced trismus in head and neck cancer patients
    Gebre-Medhin, Maria
    Haghanegi, Mahnaz
    Robert, Lotta
    Kjellen, Elisabeth
    Nilsson, Per
    ACTA ONCOLOGICA, 2016, 55 (11) : 1313 - 1317
  • [6] Dose to the masseter muscle predicts radiation-induced trismus in head and neck cancer
    Pauli, N.
    Olsson, C.
    Pettersson, N.
    Johansson, M.
    Haugen Cange, H.
    Wilderang, U.
    Steineck, G.
    Finizia, C.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S465 - S465
  • [7] Trismus Occurrence and Link With Radiotherapy Doses in Head and Neck Cancer Patients Treated With Chemoradiotherapy
    Faravel, Kerstin
    Jarlier, Marta
    Senesse, Pierre
    Huteau, Marie-Eve
    Janiszewski, Chloe
    Stoebner, Anne
    Boisselier, Pierre
    INTEGRATIVE CANCER THERAPIES, 2023, 22
  • [8] A Retrospective Review of Radiation-Induced Trismus in Head-and-Neck Cancer: An MD Anderson Experience
    Cardoso, R.
    Beadle, B.
    Chambers, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S474 - S474
  • [9] Preventing radiation-induced dysphagia and trismus in head and neck cancer-A randomized controlled trial
    Petersson, Kerstin
    Finizia, Caterina
    Pauli, Nina
    Tuomi, Lisa
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2025, 47 (01): : 159 - 174
  • [10] Impact of radiation-induced toxicities on quality of life of patients treated for head and neck cancer
    van der Laan, Hans Paul
    Van den Bosch, Lisa
    Schuit, Ewoud
    Steenbakkers, Roel J. H. M.
    van der Schaaf, Arjen
    Langendijk, Johannes A.
    RADIOTHERAPY AND ONCOLOGY, 2021, 160 : 47 - 53